Pain Management and Sedation



Pain Management and Sedation


Rahim Valani MD, CCFP-EM, FRCPC, PG Dip Med Ed



ANATOMY OF PAIN1



  • Pain is a neuro-biochemical phenomenon.


  • Nociceptors from the periphery transduce stimuli into neural impulses that are propagated to cell bodies and up the spinal cord.



    • Neuron cell bodies are in the spinal cord’s dorsal root ganglion (DRG).


  • Each spinal cord level has its own DRG, while the face has the trigeminal ganglion.


  • Two main types of receptors, the slow C-fibers and the fast Aδ fibers (Table 18-1).


  • Impulse-inducing chemicals include leukotrienes, bradykinin, serotonin, histamine, potassium, protons, acetylcholine, substance P, and platelet-activating factor.


  • The spinothalamic pathway is the main tract for pain transmission.


  • Spinothalamic pathway is divided into:



    • Lateral fast signals.



      • Travel to the brainstem’s thalamus and reticular area.


      • Help discriminate location, intensity, and duration of pain.


    • Medial slow/chronic pain.



      • Terminates in the spinal cord’s lamina II and III.


      • A multisynaptic pathway with a large terminal distribution area.


  • The thalamus is the key area for initial pain interpretation.


  • Pain is divided into somatic pain or visceral pain.


  • Visceral pain can be activated by:



    • Ischemia.


    • Chemical stimulation.


    • Spasm of hollow viscus.


    • Overdistention of hollow viscus.


CLINICAL CONSIDERATIONS IN PAIN MANAGEMENT



  • Thorough assessment of medical condition is necessary for pain management.


  • Pain affects a child’s psychological, behavioral, physiologic, and emotional state.


  • Only half of pediatric patients with significant pain receive analgesia.2, 3, 4, 5, 6, 7 and 8


  • Goal: To optimally and safely manage a patient’s pain.


  • Pediatric differences compared to adults include:



    • Cognitive abilities.


    • Developmental status.


    • Respiratory mechanics and airway anatomy.


    • Metabolism of drugs.



  • Pain assessment should be:9



    • Individualized.


    • Comprehensive.


    • Measured.


    • Continuous.


    • Monitored.


    • Documented.


  • Most reliable pain indicator is patient self-reporting.


  • There are many different pain scales in use (Fig. 18-1).


  • The American Academy of Pediatrics (AAP) and American Pain Society recommend observing behavior to complement self-reporting.



    • This is an acceptable alternative when valid self-reporting is unavailable.11








TABLE 18-1 Comparison of Different Neural Pain Fibers



























C Fibers


Aδ Fibers



80% of peripheral receptors


Activation


Mechanical, thermal, and chemical


Primarily mechanical or thermal


Myelination


Nonmyelinated


Myelinated


Speed of Impulse Propagation


Slow: 0.5-2 m/sec


Fast: 5-30 m/sec


Diameter


<1.5 µm


1-5 µm



MODES OF PAIN RELIEF



  • Two main pain relief strategies are nonpharmacologic and pharmacologic.9,11


Nonpharmacologic



  • Cognitive: Music, imagery, positive reinforcement, hypnosis.


  • Behavioral: Relaxation, biofeedback, breathing.


  • Physical: Heat/cold application, massage, touch, TENS, acupuncture, immobilization.


Pharmacologic (Fig. 18-2, Tables 18-2 and 18-3)



  • Have naloxone available in case of respiratory depression with opioids.



    • Dose: 0.1 mg/kg (maximum dose is 2 mg).


  • Narcotic clearance is slower in neonates, and increases over the first 2 to 6 months.


  • Dose accordingly.






FIGURE 18-1 • Examples of pain assessment scales.9,10







FIGURE 18-2 • Pain relief ladder. (From Kowalczyk A, ed. The 2004-2005 formulary of drugs. The Hospital for Sick Children, University of Toronto, 2004, with permission.)








TABLE 18-2 Non-Opioid Analgesia9,10,13






































Drug


Dosage


Route


Frequency


Max Dose


Acetaminophen


15 mg/kg


PO


4 hr


65 mg/kg or 4 g/day, whichever is less



30 mg/kg


PR


6 hr


Ibuprofen


10 mg/kg


PO


6 hr


40 mg/kg


Naproxen


5-10 mg/kg


PO


12 hr


1 g/day


Ketorolac


Load up to 0.5 mg/kg


IV/IM


6 hr


Maximum use of 30 mg/dose, only for 48 hours









TABLE 18-3 Opioid Analgesia9,10,13































Drug


Dosage


Route


Frequency


Max Dose


Codeine


0.5-1 mg/kg


PO


4 hr


3-6 mg/kg/day


Morphine


0.1-0.3 mg/kg


PO/PR


4 hr



0.05-0.1 mg/kg


IV


4 hr


Fentanyl


0.5-1.0 µg/kg


IV


1 hr




Jun 22, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Pain Management and Sedation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access